Vijay Sabesan is SVP & TECHNICAL OPERATIONS at Theravance Biopharma, Inc. (TBPH). They have made 1 open-market trade across 1 company since 2019, most recently 2021-11-19.
CIK 0001767807
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TBPH | 235,524 | $4.0M |
Shares reported on the most recent Form 4, priced at the 2021-11-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBPH | SELL | 2019-12-12 | 2019-12-16 | $21.03 | $22K | +13.6% | +11.6% | -21.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.